Who is likely to benefit from GLP-1 and GIP therapy
BPC-157 may accelerate this remodeling process, but I still recommend completing full protocols and progressing through proper rehabilitation before resuming high-risk activities
They were usually cheaper and easier to get, but there were concerns about how they were made and whether they were safe and effective for long-term use
Before you can inject, you must add bacteriostatic water
Meal Timing & Frequency: The Small Meal Strategy Given that GLP-1s slow digestion and promote early fullness, shifting away from the traditional three large meals a day is often beneficial
Eli Lilly published the results of its ATTAIN-1b trial for obesity in September 2025 7 , which compared orforglipron to placebo in more than 3,100 adults without diabetes, with a BMI of 30+ or 27-30 with an obesity-related complication including hypertension, dyslipidaemia, cardiovascular disease or obstructive sleep apnoea and a history of at least one patient-reported unsuccessful dietary effort to lose body weight, who have tried unsuccessfully to lose weight with diet alone